Cityslicker, thanks for reaching out to fierce publications. Someone with your background might actually find an ear with them. I have found it very frustrating over the years to never read about RVX (or Zenith) in either fierce pharma or fierce biotech both of which I read regularly. It would be nice if RVX could perform even one business function well.